CCL2 and tuberculosis: Studies have revealed that the activation of the MAPK pathway can lead to the expression of inflammatory cytokines, such as TNF-α, IL-10, and MCP-1 (monocyte chemoattractant protein-1), to aggravate TB [89,90], and the suppression of it may attenuate TB progression [91,92].